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REPROGRAMING?
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(1) Nuclear transfer(NT) 
injection of a somatic 
nucleus into an enucleated 
oocyte, can give rise to 
genetically matched 
embryonic stem (ES) cells 
(“somatic cell nuclear 
transfer,” SCNT). 
(2) a somatic cell is fused with 
an embryonic stem cell 
(ESC).
(3) Explantation of somatic 
cells in culture selects for 
immortal cell lines that may 
be pluripotent or 
multipotent.
(4) Transduction of somatic 
cells with defined factors 
can initiate reprogramming 
to a pluripotent state.
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6Materials and Methods
Cell lines and maintenance:
The A549 human alveolar adenocarcinoma cell line:  RPMI-1640 containing 10% FBS
The B16f10 cell line : DMEM containing 10 % FBS. 
The reprogrammed A549-iPSCs and B16f10-iPSCs both of which contained 15% 
KnockOut Serum Replacement .
Plasmid vectors and transfection reagents
three plasmid vectors:
These included pCXOKS-2A (encoding Oct-3/4, Sox2, and Klf4) and pCXcMyc
(encoding c-Myc) from Addgene for iPSC induction 
pIRES2-EGFP from Clontech for the assessment of cell transfection efficiency. 
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DISCUSSION:
the initial cell density seeded in culture is 
one of the most critical parameters to 
consider to achieve a high reprogramming 
efficacy for C-iPSCs induction and 
establishment
as high as 50% of the cells or more with 
typical iPSCs morphology and phenotypic 
markers could be consistently achieved. 
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